Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression
2010 ◽
Vol 94
(1)
◽
pp. 167-172
◽
2002 ◽
Vol 78
(5)
◽
pp. 1025-1029
◽
2004 ◽
Vol 18
(6)
◽
pp. 335-340
◽
2002 ◽
Vol 64
(8)
◽
pp. 731-734
◽
1990 ◽
Vol 7
(3)
◽
pp. 172-176
◽
2011 ◽
Vol 96
(5)
◽
pp. 1112-1115
◽
2005 ◽
Vol 84
(5)
◽
pp. 1529-1532
◽